The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Long-term effect of united hepatectomy and splenectomy on treatment of hepatocellular carcinoma complicated with cirrhosis and hypersplenism
Author(s): 
Pages: 6-8
Year: Issue:  1
Journal: NATIONAL MEDICAL JOURNAL OF CHINA

Keyword:  肝细胞肝硬化脾功能亢进肝脾联合切除预后;
Abstract: 目的探讨肝脾联合切除术治疗肝癌合并肝硬化脾功能亢进的远期疗效.方法对102例肝癌合并肝硬化脾功能亢进患者的临床资料进行回顾性分析.57例行肝脾联合切除术(A组),45例行单纯肝切除术(B组).结果 A、B两组术中出血及术后并发症的发生率差异均无显著意义(P>0.05),但术后血小板、白细胞的回升及与肝硬化预后相关的指标谷氨酰转肽酶(GGT)数值的改善,A组明显好于B组(P<0.05).两组1、3、5年复发率分别为27.1%、48.6%、69.3%及41.2%、50.0%、77.9%;生存率分别为92.6%、59.1%、41.8%及80.3%、43.9%、29.1%,两组虽然没有统计学差异,但A组的生存情况均好于B组,而且A组复发患者的平均带瘤生存期(12.9个月)亦明显长于B组(6.3个月,P<0.01).结论肝脾联合切除术治疗肝癌合并肝硬化脾功能亢进不但具有良好的安全性且长期随访的结果是满意的.
Related Articles
loading...